Data were collected at three different time points: baseline, 4, and 8 weeks. The primary inclusion criteria included patients between 30 and 65 years old with chronic pain who have been on opioids for at least 1 year. Ninety-seven patients completed the 8-week study. Methods: An initial sample of 131 patients was recruited from a private pain management center’s investigative population. Objectives: We aim to investigate the impact of full hemp extract cannabidiol (CBD) on opioid use and quality of life indicators among chronic pain patients. Cannabinoids, and specifically Cannabidiol, is proposed as an opioid alternative, having comparable efficacy with better safety profile. Despite the documented adverse effects, opioids are widely used for pain management. Context: Chronic pain is highly prevalent in most of the industrialized nations around the world.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |